1. Home
  2. ETS vs ENLV Comparison

ETS vs ENLV Comparison

Compare ETS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

N/A

Current Price

$1.48

Market Cap

12.0M

Sector

Industrials

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

N/A

Current Price

$0.28

Market Cap

10.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETS
ENLV
Founded
2020
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
10.4M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
ETS
ENLV
Price
$1.48
$0.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
304.2K
★ 1.7M
Earning Date
10-20-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,665,948.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 21.57
N/A
52 Week Low
$0.39
$0.26
52 Week High
$2.75
$7.64

Technical Indicators

Market Signals
Indicator
ETS
ENLV
Relative Strength Index (RSI) 48.97 18.31
Support Level $1.42 N/A
Resistance Level $1.88 $1.26
Average True Range (ATR) 0.25 0.09
MACD -0.06 0.01
Stochastic Oscillator 6.77 8.34

Price Performance

Historical Comparison
ETS
ENLV

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: